Suppr超能文献

流式细胞术检测的S期细胞分数作为非霍奇金淋巴瘤细胞学分级的补充生物学参数。

Flow cytometric S-phase fraction as a complementary biological parameter for the cytological grading of non-Hodgkin's lymphoma.

作者信息

Pinto António E, Cabeçadas José, Nóbrega Sónia D, Mendonça Evelina

机构信息

Department of Morphologic Pathology, Portuguese Oncologic Institute, Lisbon Center, Portugal.

出版信息

Diagn Cytopathol. 2003 Oct;29(4):194-9. doi: 10.1002/dc.10298.

Abstract

Fine-needle aspiration cytology (FNAC) is a technique that can overcome tissue-sampling disaggregation problems related to DNA flow cytometry analysis. The aim of this study, with long-term follow-up (median, 72 mo), was to investigate the prognostic value of DNA ploidy and S-phase fraction (SPF) in patients with non-Hodgkin's lymphoma (NHL), and additionally, the relevance of SPF in the grading of NHLs, using FNAC. The series comprised 76 patients with NHL (32 indolent and 44 aggressive tumors, including 14 Burkitt lymphomas) and 30 patients with reactive lymph node enlargement used as a control group. DNA flow cytometry was performed on fresh samples obtained by FNAC. NHL grading was done according to the updated Kiel classification. The 5-yr overall survival of patients with NHL was determined using the Kaplan-Meier method. All samples of the control group and 81.6% of the NHLs showed a DNA diploid pattern. Fourteen cases (18.4%) were DNA aneuploid with bimodal distribution: slight hyperdiploidy and near-tetraploidy. Despite the higher incidence of aneuploidy in aggressive than in indolent tumors (22.7% vs. 12.5%), no correlation between DNA ploidy and NHL grading was observed. In contrast, SPF revealed a strong correlation with grading (P=0.0001). The mean SPF values varied from 6.5% in indolent NHLs, to 20.4% in aggressive not-otherwise-specified (NOS) NHLs, and to 35.3% in Burkitt lymphomas. Nearly all aggressive NHLs had an SPF >15%, while the vast majority of indolent NHLs showed an SPF <10%. The mean SPF value in the reactive node group was 6.6%. NHL grading significantly was correlated to survival (P=0.004) only if the Burkitt lymphomas, which showed the best prognosis, were analyzed as an independent group. There was a trend that did not reach statistical significance (P=0.072) for a worse clinical outcome of patients with aneuploid tumors. When mean SPF values were used as cutoff points to divide both indolent NHLs and aggressive NOS NHLs into two proliferative subgroups, no differences in relation to survival were found (P=0.763 and P=0.994, respectively). Also, no proliferative difference was verified between indolent NHLs and the reactive lymph node group (P=0.223). These results show that flow cytometric SPF is a valuable complementary parameter for grading NHLs on FNAC samples, but it appears to give no additional prognostic information on subset analyses.

摘要

细针穿刺细胞学检查(FNAC)是一种能够克服与DNA流式细胞术分析相关的组织采样解离问题的技术。本研究旨在通过长期随访(中位数为72个月),探讨DNA倍体和S期分数(SPF)在非霍奇金淋巴瘤(NHL)患者中的预后价值,此外,还利用FNAC研究SPF在NHL分级中的相关性。该系列包括76例NHL患者(32例惰性肿瘤和44例侵袭性肿瘤,包括14例伯基特淋巴瘤)以及30例反应性淋巴结肿大患者作为对照组。对通过FNAC获取的新鲜样本进行DNA流式细胞术检测。NHL分级根据更新后的基尔分类法进行。采用Kaplan-Meier方法确定NHL患者的5年总生存率。对照组的所有样本以及81.6%的NHL显示出DNA二倍体模式。14例(18.4%)为DNA非整倍体,呈双峰分布:轻度超二倍体和近四倍体。尽管侵袭性肿瘤中非整倍体的发生率高于惰性肿瘤(22.7%对12.5%),但未观察到DNA倍体与NHL分级之间的相关性。相反,SPF与分级显示出强烈相关性(P=0.0001)。SPF的平均值在惰性NHL中为6.5%,在侵袭性未另行指定(NOS)的NHL中为20.4%,在伯基特淋巴瘤中为35.3%。几乎所有侵袭性NHL的SPF>15%,而绝大多数惰性NHL的SPF<10%。反应性淋巴结组的平均SPF值为6.6%。仅将预后最佳的伯基特淋巴瘤作为独立组进行分析时,NHL分级与生存率显著相关(P=0.004)。非整倍体肿瘤患者临床结局较差存在一种未达到统计学显著性的趋势(P=0.072)。当将平均SPF值作为分界点将惰性NHL和侵袭性NOS NHL均分为两个增殖亚组时,未发现与生存率相关的差异(分别为P=0.763和P=0.994)。此外,惰性NHL与反应性淋巴结组之间未证实存在增殖差异(P=0.223)。这些结果表明,流式细胞术检测的SPF是对FNAC样本上的NHL进行分级的有价值的补充参数,但在亚组分析中似乎并未提供额外的预后信息。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验